Article

AMO introduces three refractive technologies in Europe

Santa Ana, CA-Advanced Medical Optics Inc. (AMO) launched three refractive technologies to the European market at the annual meeting of the European Society of Cataract and Refractive Surgeons in Stockholm, Sweden.

Santa Ana, CA-Advanced Medical Optics Inc. (AMO) launched three refractive technologies to the European market at the annual meeting of the European Society of Cataract and Refractive Surgeons in Stockholm, Sweden. A one-piece IOL (Tecnis 1-Piece) and a multifocal acrylic IOL (Tecnis Multifocal) were introduced for the first time in any market, and a phacoemulsification system (WhiteStar Signature) that was launched in the United States in April at the American Society of Cataract and Refractive Surgery was introduced in the European market.

The one-piece lens aims to reduce spherical aberration and improve functional vision. Its design includes a 360° edge with an uninterrupted barrier edge to minimize cell migration onto the posterior capsule; no interruption at the haptic-optic junction; a frosted edge to minimize edge glare; and three-point fixation to address stability issues. It is made of a hydrophobic acrylic material that blocks ultraviolet (UV) light.

AMO expects to launch the one-piece IOL in the United States in the first half of 2008.

The multifocal IOL, which has been available in a silicone material for 3 years, now is available in a hydrophobic acrylic material in Europe. The material helps lower chromatic dispersion for improved vision, according to the company.

The lens uses a patented, wavefront-designed aspheric surface to compensate for spherical aberration of the cornea. It is the only lens on the market designed to correct both spherical aberration and chromatic aberration, according to the company.

Its full diffractive posterior surface allows a full range of quality vision, independent of pupil size, allowing the lens to perform well in low-light situations, according to the company. It also is made of a hydrophobic acrylic material that blocks UV light.

The new phacoemulsification system features a streamlined user interface and accessories designed to enhance the efficiency of the operating room environment. Fluidics technology offers high flow and vacuum capabilities. Other features include a one-step auto-loading tubing pack, a faster prime cycle, a touch screen designed to be more intuitive, a wireless foot pedal, voice confirmation, and greater ease of programming, according to the company. Also, a surgical media center offers real-time blending of system data and surgical video; customized viewing of procedures and data; high-definition, customizable presentation capability; and a frame-by-frame teaching tool.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.